Clinical Researh Malaysia (CRM) is looking for Psoriatic Arthritis (PsA) patients who have been previously treated with one biologic Anti-Tumor Necrosis Factor (anti-TNF)) with unsatisfactory outcome. Participants will be provided a new biologic that is not an anti-TNF as part of the clinical trial for approximately 24 months.
For those interested to enter the clinical trial and find out if you are eligible, please contact:
Syazrin Aminah Binti Mohd Noor (Recruitment Specialist For Clinical Research Malaysia)
Email: syazrin@clinicalresearch.my
Telephone: +603-7931 5566 (ext. 115)
D-26-06, Menara Suezcap 1,
KL Gateway, No. 2 Jalan Kerinchi,
Gerbang Kerinchi Lestari,
59200 Kuala Lumpur, Malaysia.
Closing date for patient registration is 31 Dec 2022 (subject to change)
For more information, view posters below.
Comments